93 related articles for article (PubMed ID: 9330619)
21. Can We Improve Diosmetin Activity? The State-of-the-Art and Promising Research Directions.
Wujec M; Feldo M
Molecules; 2023 Dec; 28(23):. PubMed ID: 38067639
[TBL] [Abstract][Full Text] [Related]
22. Multimodal Carbon Monoxide Photorelease from Flavonoids.
Ramundo A; Hurtová M; Božek I; Osifová Z; Russo M; Ngoy BP; Křen V; Klán P
Org Lett; 2024 Jan; 26(3):708-712. PubMed ID: 38227978
[TBL] [Abstract][Full Text] [Related]
23. The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds.
Ntuli SSBN; Gelderblom WCA; Katerere DR
BMC Complement Altern Med; 2018 Mar; 18(1):93. PubMed ID: 29544492
[TBL] [Abstract][Full Text] [Related]
24. Antimutagenic and anticlastogenic effects of Turkish Black Tea on TA98 and TA100 strains of Salmonella typhimurium (in vitro) and mice (in vivo).
Charehsaz M; Sipahi H; Giri AK; Aydin A
Pharm Biol; 2017 Dec; 55(1):1202-1206. PubMed ID: 28245735
[TBL] [Abstract][Full Text] [Related]
25. In vitro antioxidant, anti-diabetic and antilipemic potentials of quercetagetin extracted from marigold (Tagetes erecta L.) inflorescence residues.
Wang W; Xu H; Chen H; Tai K; Liu F; Gao Y
J Food Sci Technol; 2016 Jun; 53(6):2614-24. PubMed ID: 27478217
[TBL] [Abstract][Full Text] [Related]
26. Isorhamnetin 3-O-robinobioside from Nitraria retusa leaves enhance antioxidant and antigenotoxic activity in human chronic myelogenous leukemia cell line K562.
Boubaker J; Ben Sghaier M; Skandrani I; Ghedira K; Chekir-Ghedira L
BMC Complement Altern Med; 2012 Aug; 12():135. PubMed ID: 22913434
[TBL] [Abstract][Full Text] [Related]
27. Diosmin pretreatment affects bioavailability of metronidazole.
Rajnarayana K; Reddy MS; Krishna DR
Eur J Clin Pharmacol; 2003 Apr; 58(12):803-7. PubMed ID: 12698306
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of dietary flavonoids in liver microsomes.
Xiao J; Högger P
Curr Drug Metab; 2013 May; 14(4):381-91. PubMed ID: 23330926
[TBL] [Abstract][Full Text] [Related]
29. N-nitrosamines: bacterial mutagenesis and in vitro metabolism.
Guttenplan JB
Mutat Res; 1987 Sep; 186(2):81-134. PubMed ID: 3306361
[TBL] [Abstract][Full Text] [Related]
30. The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinoline.
Lee H; Wang HW; Su HY; Hao NJ
Mutagenesis; 1994 Mar; 9(2):101-6. PubMed ID: 8201941
[TBL] [Abstract][Full Text] [Related]
31. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and other heterocyclic amine mutagens from cooked food.
Edenharder R; von Petersdorff I; Rauscher R
Mutat Res; 1993 Jun; 287(2):261-74. PubMed ID: 7685486
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline.
Hao NJ; Huang MP; Lee H
Mutat Res; 1995 May; 328(2):183-91. PubMed ID: 7739602
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the mutagenicity of 2-nitrofluorene, 3-nitrofluoranthene and 1-nitropyrene by flavonoids, coumarins, quinones and other phenolic compounds.
Edenharder R; Tang X
Food Chem Toxicol; 1997; 35(3-4):357-72. PubMed ID: 9207898
[TBL] [Abstract][Full Text] [Related]
34. Antimutagenic effects and possible mechanisms of action of vitamins and related compounds against genotoxic heterocyclic amines from cooked food.
Edenharder R; Worf-Wandelburg A; Decker M; Platt KL
Mutat Res; 1999 Jul; 444(1):235-48. PubMed ID: 10477359
[TBL] [Abstract][Full Text] [Related]
35. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
Edenharder R; Rauscher R; Platt KL
Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
